Palo Alto Investors LP - IMMUNOMEDICS INC ownership

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$412,598,000
+124.6%
4,852,383
-6.4%
22.65%
+105.3%
Q2 2020$183,685,000
+157.6%
5,182,983
-2.0%
11.03%
+84.7%
Q1 2020$71,319,000
-43.1%
5,290,746
-10.7%
5.97%
-13.5%
Q4 2019$125,335,000
+52.8%
5,923,195
-4.2%
6.90%
+26.3%
Q3 2019$82,004,000
-11.4%
6,184,320
-7.4%
5.46%
+21.3%
Q2 2019$92,607,000
-24.5%
6,676,755
+4.6%
4.50%
-12.0%
Q1 2019$122,590,000
+65.6%
6,381,555
+23.0%
5.11%
+29.8%
Q4 2018$74,008,000
-29.1%
5,186,255
+3.4%
3.94%
-6.7%
Q3 2018$104,437,000
-8.1%
5,013,764
+4.4%
4.22%
-7.1%
Q2 2018$113,696,000
+62.3%
4,803,364
+0.2%
4.54%
+51.6%
Q1 2018$70,070,000
-9.2%
4,796,008
+0.5%
3.00%
-9.8%
Q4 2017$77,152,000
+83.3%
4,774,261
+58.6%
3.32%
+87.4%
Q3 2017$42,086,000
+58.3%
3,010,4660.0%1.77%
+42.9%
Q2 2017$26,582,0003,010,4661.24%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q2 2024.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders